Bioavailability of BI 10773 and Sitagliptin in Healthy Male Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective was to investigate whether there was a drug-drug interaction between BI 10773
and sitagliptin when co-administered as multiple oral doses. Therefore, the relative
bioavailabilities of BI 10773 and sitagliptin were determined when both drugs were given in
combination compared with BI 10773 or sitagliptin given alone.